Livzon Pharmaceutical Group's market cap is currently ―. The company's EPS TTM is $0.297; its P/E ratio is 11.22; and it has a dividend yield of 6.63%. Livzon Pharmaceutical Group is scheduled to report earnings on August 21, 2024, and the estimated EPS forecast is $0.08. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22
Income Statement	-
Total Revenue	¥ 3.41B	¥ 3.14B	¥ 3.19B	¥ 2.82B	¥ 3.48B
Gross Profit	¥ 2.15B	¥ 1.95B	¥ 2.10B	¥ 1.81B	¥ 2.30B
EBIT	¥ 758.08M	¥ 491.21M	¥ 566.89M	¥ 622.76M	¥ 747.24M
EBITDA	¥ 758.08M	¥ 491.21M	¥ 566.89M	¥ 622.76M	¥ 747.24M
Net Income Common Stockholders	¥ 581.91M	¥ 402.59M	¥ 489.25M	¥ 464.25M	¥ 553.29M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	¥ 10.95B	¥ 10.52B	¥ 9.75B	¥ 9.33B	¥ 10.12B
Total Assets	¥ 25.62B	¥ 24.86B	¥ 23.57B	¥ 22.94B	¥ 23.73B
Total Debt	¥ 4.05B	¥ 3.62B	¥ 3.51B	¥ 3.29B	¥ 3.05B
Net Debt	¥ -6.90B	¥ -6.90B	¥ -6.24B	¥ -6.04B	¥ -7.06B
Total Liabilities	¥ 10.20B	¥ 9.93B	¥ 9.06B	¥ 8.95B	¥ 8.80B
Stockholders Equity	¥ 14.28B	¥ 13.88B	¥ 13.43B	¥ 12.87B	¥ 13.56B
Cash Flow	-
Free Cash Flow	¥ 153.37M	¥ 775.03M	¥ 223.58M	¥ 324.82M	¥ 509.09M
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	¥ -64.83M	¥ -460.82M	¥ -206.40M	¥ -344.15M	¥ -218.51M
Financing Cash Flow	¥ 316.69M	¥ 37.23M	¥ 99.84M	¥ -1.21B	¥ 353.34M

Currency in CNY

Livzon Pharmaceutical Group Earnings and Revenue History

Income Statement >

Livzon Pharmaceutical Group Debt to Assets

Balance Sheet >

Livzon Pharmaceutical Group Cash Flow

Cash Flow >

Livzon Pharmaceutical Group Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing